Aviso Financial Inc. Increases Stock Holdings in CME Group Inc. $CME

Key Points

• Aviso Financial Inc. increased its holdings in CME Group Inc. by 6.2%, reaching a total of 24,399 shares valued at approximately $6.47 million as of the end of the first quarter.
• Research analysts have varying ratings for CME Group, with a consensus rating of "Hold" and an average price target of $261.93, although Piper Sandler recently raised their target to $296.00.
• CME Group announced a quarterly dividend of $1.25 per share, which equates to an annualized dividend yield of 1.8%, set to be paid on September 25th.

Aviso Financial Inc. raised its position in CME Group Inc. (NASDAQ:CME - Free Report) by 6.2% during the first quarter, according to its most recent filing with the SEC. The firm owned 24,399 shares of the financial services provider's stock after purchasing an additional 1,433 shares during the period. Aviso Financial Inc.'s holdings in CME Group were worth $6,473,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CME. Price T Rowe Associates Inc. MD lifted its position in shares of CME Group by 89.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after purchasing an additional 3,921,278 shares during the period. GQG Partners LLC lifted its position in shares of CME Group by 7,676.3% during the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock valued at $584,975,000 after acquiring an additional 2,176,685 shares during the period. GAMMA Investing LLC lifted its position in shares of CME Group by 32,941.0% during the 1st quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after acquiring an additional 1,853,261 shares during the period. Nuveen LLC acquired a new position in shares of CME Group during the 1st quarter valued at $218,842,000. Finally, Egerton Capital UK LLP lifted its position in shares of CME Group by 79.4% during the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider's stock valued at $459,003,000 after acquiring an additional 765,773 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Wall Street Analyst Weigh In

CME has been the topic of a number of research reports. Barclays set a $298.00 target price on shares of CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. JPMorgan Chase & Co. dropped their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. UBS Group reiterated a "neutral" rating and set a $305.00 target price on shares of CME Group in a research report on Thursday, July 24th. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, CME Group presently has an average rating of "Hold" and an average target price of $261.93.

Insider Activity

In other CME Group news, Director Charles P. Carey sold 500 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director directly owned 4,900 shares of the company's stock, valued at $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William R. Shepard acquired 256 shares of the company's stock in a transaction on Wednesday, June 25th. The shares were acquired at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Down 1.4%

Shares of NASDAQ CME traded down $3.80 during trading on Friday, hitting $269.52. The stock had a trading volume of 1,579,124 shares, compared to its average volume of 2,326,034. CME Group Inc. has a 12 month low of $206.44 and a 12 month high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $97.13 billion, a PE ratio of 26.09, a PEG ratio of 4.97 and a beta of 0.44. The firm has a fifty day moving average of $275.82 and a two-hundred day moving average of $268.13.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.56 earnings per share. As a group, equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's dividend payout ratio is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.